Page last updated: 2024-09-04

cyc 202 and zd 9331

cyc 202 has been researched along with zd 9331 in 1 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (zd 9331)	Trials (zd 9331)	Recent Studies (post-2010) (zd 9331)
979	7	393	55	17	2

Protein Interaction Comparison

Protein	Taxonomy	cyc 202 (IC50)	zd 9331 (IC50)
Thymidylate synthase	Mus musculus (house mouse)		0.0014

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doyle, B; Geller, JI; Houghton, JA; Petak, I; Szekely-Szucs, K	1

Other Studies

1 other study(ies) available for cyc 202 and zd 9331

Article	Year
P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells. Cancer research, 2004, Sep-01, Volume: 64, Issue:17 Topics: Apoptosis; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Enzyme Inhibitors; fas Receptor; G1 Phase; HCT116 Cells; HT29 Cells; Humans; Interferon-gamma; Purines; Quinazolines; Roscovitine; S Phase; Thymidylate Synthase	2004

Article

Year

P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells.

Cancer research, 2004, Sep-01, Volume: 64, Issue:17

Topics: Apoptosis; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Enzyme Inhibitors; fas Receptor; G1 Phase; HCT116 Cells; HT29 Cells; Humans; Interferon-gamma; Purines; Quinazolines; Roscovitine; S Phase; Thymidylate Synthase

2004